Retrieve Medical Holdings - 15 Year Stock Price History | RMHI
Historical daily share price chart and data for Retrieve Medical Holdings since 2010 adjusted for splits and dividends. The latest closing stock price for Retrieve Medical Holdings as of May 16, 2025 is 2.50.
- The all-time high Retrieve Medical Holdings stock closing price was 7.05 on February 27, 2025.
- The Retrieve Medical Holdings 52-week high stock price is 7.50, which is 200% above the current share price.
- The Retrieve Medical Holdings 52-week low stock price is 0.25, which is 90% below the current share price.
- The average Retrieve Medical Holdings stock price for the last 52 weeks is 2.75.
| Retrieve Medical Holdings Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.7713 | 1.0700 | 7.0500 | 1.0700 | 2.5000 | 133.64% |
| 2024 | 2.4616 | 1.8980 | 5.5500 | 0.2500 | 1.0700 | -38.15% |
| 2023 | 3.0432 | 0.1300 | 7.0000 | 0.0300 | 1.7300 | 1153.62% |
| 2022 | 0.0644 | 0.0880 | 0.1440 | 0.0380 | 0.1380 | 70.37% |
| 2021 | 0.1160 | 0.1000 | 0.2500 | 0.0510 | 0.0810 | -2.41% |
| 2020 | 0.0168 | 0.0090 | 0.0850 | 0.0090 | 0.0830 | 538.46% |
| 2019 | 0.0506 | 0.1100 | 0.1300 | 0.0110 | 0.0130 | -89.17% |
| 2018 | 0.1258 | 0.2200 | 0.3260 | 0.0570 | 0.1200 | -20.00% |
| 2017 | 0.0517 | 0.0500 | 0.1500 | 0.0200 | 0.1500 | 275.00% |
| 2016 | 0.0272 | 0.0260 | 0.0750 | 0.0110 | 0.0400 | 48.15% |
| 2015 | 0.1316 | 0.1300 | 0.5200 | 0.0210 | 0.0270 | -86.36% |
| 2014 | 0.6656 | 0.0115 | 1.5500 | 0.0115 | 0.1980 | 1621.74% |
| 2013 | 0.0117 | 0.0125 | 0.0125 | 0.0110 | 0.0115 | 0.00% |
| 2011 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.059B | $0.000B |
| Retrieve Medical Inc. is a software company. It is commercializing a patented Clinical Documentation Improvement platform, Retrieve Dx(TM), which enhances physician ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more. Retrieve Medical Inc., formerly known as Peak Pharmaceuticals Inc., is based in SCOTTSDALE, AZ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.988B | 53.85 |
| Hims & Hers Health (HIMS) | United States | $13.954B | 144.98 |
| Tempus AI (TEM) | United States | $10.977B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.526B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.418B | 69.02 |
| Privia Health (PRVA) | United States | $3.048B | 208.33 |
| Enovis (ENOV) | United States | $2.027B | 11.30 |
| Clover Health Investments (CLOV) | United States | $1.832B | 0.00 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.305B | 23.02 |
| Azenta (AZTA) | United States | $1.242B | 57.70 |
| 10x Genomics (TXG) | United States | $1.100B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.574B | 0.00 |
| Talkspace (TALK) | United States | $0.504B | 150.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.452B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.00 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.231B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |